GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,094,000 | +9.2% | 116,947 | +21.5% | 7.68% | -4.5% |
| Q2 2017 | $4,665,000 | +18.5% | 96,257 | +5.2% | 8.03% | +55.0% |
| Q1 2017 | $3,937,000 | +36.4% | 91,529 | -56.6% | 5.18% | +56.3% |
| Q4 2016 | $2,887,000 | -47.7% | 210,800 | +0.4% | 3.32% | -24.2% |
| Q3 2016 | $5,517,000 | +194.6% | 210,000 | +19.8% | 4.37% | +172.0% |
| Q2 2016 | $1,873,000 | +90.9% | 175,300 | +64.0% | 1.61% | +56.6% |
| Q1 2016 | $981,000 | -33.9% | 106,900 | +18.6% | 1.03% | -6.2% |
| Q4 2015 | $1,484,000 | – | 90,100 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |